Header cover image
  • Investing Ideas
  • Finnish Pharmaceuticals & Biotech High Return On Equity, Low Debt

Finnish Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Orion Oyj

Market Cap: €11.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€79.25

7D

1.5%

1Y

14.3%